排序方式: 共有13条查询结果,搜索用时 0 毫秒
11.
Eliane Sardh Pauline Harper Dan E.H. Andersson Ylva Floderus 《European Journal of Internal Medicine》2009,20(2):201-207
BackgroundAcute intermittent porphyria (AIP) is a metabolic disease affecting hepatic heme biosynthesis. The clinical course in overt disease is characterized by acute attacks of neurovisceral symptoms. Treatment is based on symptomatic relief together with carbohydrate loading and in more severe attacks heme therapy.During an acute attack the heme precursors porphobilinogen (PBG) and 5-aminolevulinic acid (ALA) are produced in high amounts by the liver and are found in high concentrations in plasma and urine. These metabolites represent the acute phase reactants confirming an ongoing attack and are used to evaluate therapeutic measures.The aim of this study was to measure PBG and ALA in plasma and urine during an acute attack and to match the biochemical pattern with the clinical and therapeutical course.MethodsThree consecutive AIP patients were included during four acute attacks. Plasma PBG and ALA were measured by a LC-MS method and in urine by ion-exchange chromatography. The patients received symptomatic and glucose treatment at admission to hospital, and four days later, if necessary, heme therapy.ResultsIn the three attacks that required heme therapy, plasma PBG concentrations had further increased after admission (p = 0.01). In the patient that did not require heme therapy, plasma PBG had decreased after admission.ConclusionsBiochemical monitoring of an acute attack was more accurately reflected by plasma PBG than plasma ALA or urinary PBG and ALA. Glucose administration, in contrast to heme therapy, was not sufficient to achieve clinical and biochemical remission in the more serious attacks. 相似文献
12.
Staffan Wahlin Pauline Harper Eliane Sardh Christer Andersson Dan EH Andersson Bo‐Göran Ericzon 《Transplant international》2010,23(6):e18-e21
We report two patients with acute intermittent porphyria (AIP) who were successfully treated with combined liver and kidney transplantation. Both had a very poor quality of life as a result of years of frequent acute porphyria symptoms, chronic peripheral neuropathy and renal failure requiring dialysis. After transplantation, clinical and biochemical signs of porphyria disappeared. The excretion pattern of porphyrin precursors normalized within the first day and plasma porphyrins returned to normal within a week. These and other recent cases have clarified previous concerns and have helped to formulate the indications for and the timing of transplantation in AIP. 相似文献
13.
Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver 下载免费PDF全文
C. Schmitt H. Lenglet A. Yu C. Delaby A. Benecke T. Lefebvre P. Letteron V. Paradis S. Wahlin S. Sandberg P. Harper E. Sardh A. K. Sandvik J. R. Hov A. K. Aarsand L. Chiche C. Bazille J.‐Y. Scoazec J. To-Figueras M. Carrascal J. Abian A. Mirmiran Z. Karim J.‐C. Deybach H. Puy K. Peoc'h H. Manceau L. Gouya 《Journal of internal medicine》2018,284(1):78-91